Login
$GNLX
$1.80 -$0.12 (6.16%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Thomas D. Zindrick Also a director
President, Chief Executive Officer and Chairman
67 Not stated $4,277,083
Matthew Pulisic
Chief Financial Officer
42 Since 2025
1 year
$1,487,011
Jason Litten
Chief Medical Officer
52 Since 2026
this year
Not reported
Joseph Cappello
Chief Technical Officer
69 Since 2023
3 years
$1,442,092
Eric Groen
General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
55 Since 2025
1 year
Not reported
Yong Yu
Chief Scientific Officer
Title from the Form 4 dated Nov 3, 2026
Not stated Not stated Not reported
Tony Yu
Senior Vice President, Clinical Development
55 Since 2023
3 years
Not reported
Ralph Smalling
Head of Regulatory
70 Since 2023
3 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
4 of 4
stated in the proxy; 1 not stated
Average tenure
11.6 years
from year joined
CEO also chairs the board
Yes
Thomas D. Zindrick, J.D.
Director Age On board Independent Other public boards 2025 pay Source
Thomas D. Zindrick, J.D.
67 2014
12 years
Not stated None stated Paid as CEO
James L. Tyree
73 2012
14 years
Independent None stated $264,009
John Smither
73 2023
3 years
Independent NewAmsterdam Pharma Not stated
Mary Mirabelli
69 2021
5 years
Independent None stated Not stated
John Thomas, Ph.D.
68 2002
24 years
Independent None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support